Press Release
  •  
October 29, 2021

Morgan Stanley Infrastructure Partners Completes Investment in SpecialtyCare

 

Press Release

Morgan Stanley Infrastructure Partners Completes Investment in SpecialtyCare

Morgan Stanley Infrastructure Partners Completes Investment in SpecialtyCare

Share Icon

October 29, 2021

 
 

NEW YORK — October 29, 2021 12:45 EDT

Investment funds managed by Morgan Stanley Infrastructure Partners (“MSIP”), a private infrastructure team within Morgan Stanley Investment Management, announced today that they have acquired SpecialtyCare, Inc. (“SpecialtyCare” or the “Company”) from Kohlberg & Company, LLC (“Kohlberg”).

SpecialtyCare operates the leading network of outsourced clinical services to hospital operating rooms in the U.S. With 1,200+ client hospitals in 46 U.S. states, it is the leading provider of cardiovascular perfusion, extracorporeal membrane oxygenation (“ECMO”), intraoperative neuromonitoring (“IONM”), and autologous perfusion services (“ATS”). Furthermore, SpecialtyCare is a leading provider of sterile processing services, endoscopic support and surgical assistance.

“We believe that SpecialtyCare provides an essential solution to its partners in an industry with considerable tailwinds through a contracted business model. We look forward to building upon the Company’s successful track record and further supporting their growth trajectory,” said Chris Ortega, Managing Director and Head of the Americas for MSIP.

Sam Weinstein, SpecialtyCare’s CEO said, “We are thrilled to be aligned with MSIP as we continue to pursue opportunities to improve patient care outcomes and grow our impact. We believe working with MSIP can allow us to further invest in our team with a continued focus on enhancing our strong culture.”

About Morgan Stanley Infrastructure Partners
Morgan Stanley Infrastructure Partners (“MSIP”) is a leading global private infrastructure investment platform with over $16 billion in assets under management1. Founded in 2006, MSIP has invested in a diverse portfolio of over 30 investments across transport, digital infrastructure, energy transition and utilities. MSIP targets assets that provide essential public goods and services with the potential for value creation through active asset management. For further information about Morgan Stanley Infrastructure Partners, please visit www.morganstanley.com/im/infrastructurepartners.

About SpecialtyCare

With over 1,500 clinicians supporting over 500,000 procedures annually, SpecialtyCare provides high quality people, services, and technology to the operating room. More than 1,200+ hospitals and 13,500 physicians trust SpecialtyCare to help them achieve exceptional care outcomes, regulatory compliance, and financial results. By maintaining the SpecialtyCare Operative Procedural Registry (SCOPE™), the largest procedural database of its kind, SpecialtyCare identifies standards, determines benchmarks, disseminates best practices, and fosters innovations and efficiencies that improve patient outcomes. Accredited and certified by The Joint Commission, SpecialtyCare develops expertise beyond industry requirements. Customers trust SpecialtyCare’s highly trained clinicians delivering excellence in perfusion, ECMO, intraoperative neuromonitoring, neurodiagnostic services, autotransfusion, sterile processing management, surgical assist, and minimally invasive surgical support.

_________________________

AUM reflects assets managed by MSIP platform since inception

 
 
 
Morgan Stanley Infrastructure Partners invests in a diverse range of infrastructure assets predominantly located in OECD countries. The team seeks to create value through active asset management and operational improvements.
 
 

Morgan Stanley Investment Management (Australia) Pty Limited operates under AFSL No: 314182.

Not to be shown, quoted or distributed to the public. The information shown in this website is not personal advice and does not take into account the investment objectives, financial situation or needs of any person.

Information on this website should not be considered a solicitation to buy, an offer to sell or a recommendation for any security in any jurisdiction where such an offer, solicitation or recommendation would be unlawful or unauthorized. In addition, investments may not be made via this website.

Past performance of any product described on this site is not a reliable indication of future performance.


Subscriptions    •    Privacy & Cookies    •    Your Privacy Choices Your Privacy Choices Icon    •    Terms of Use

©  Morgan Stanley | Investment Management (Australia) Pty Limited ACN 122040037